March 22, 2012 10:33 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Galena Biopharma (NASDAQ: GALE) are higher on the session by 13.32%, currently trading at $3.139. The stock has been moving largely higher over the past three weeks and is currently trading above the 50-day moving average.Options traders are focusing on calls today. The strike seeing the heaviest volume is the April 2012 $1.00 call, which has traded 5,700 times on open interest of 1,008 contracts. Calls are outpacing puts today by 6 to 1. Galena Biopharma, Inc., formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and immunotherapy technologies.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.